Condition
Expressive Writing
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown1
Withdrawn1
Clinical Trials (2)
Showing 2 of 2 trials
NCT05559944Not ApplicableWithdrawnPrimary
Brief Writing Programs for Sexual Minority Young Adults in Alabama
NCT04843358Not ApplicableUnknown
Efficacy of Expressive Writing on Quality of Life Among Breast Cancer Survivors in Oman: A Double Blind Randomized Controlled Trial
Showing all 2 trials